{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T03:11:20Z","timestamp":1787886680227,"version":"build-2784847793"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We retrospectively evaluated off-label use of dalbavancin as secondary therapy in 32 patients with serious Staphylococcus aureus infections (endocarditis, osteomyelitis, septic thrombophlebitis, epidural infection) who were also persons who use drugs. The majority of patients (56%) had a clinical response to treatment. Only 1 patient who completed the intended dalbavancin course experienced a treatment failure.<\/jats:p>","DOI":"10.1093\/ofid\/ofz028","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:42:04Z","timestamp":1548855724000},"source":"Crossref","is-referenced-by-count":71,"title":["Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-4012","authenticated-orcid":false,"given":"Chloe","family":"Bryson-Cahn","sequence":"first","affiliation":[{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington"},{"name":"Harborview Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9411-699X","authenticated-orcid":false,"given":"Alison M","family":"Beieler","sequence":"additional","affiliation":[{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington"},{"name":"Harborview Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie D","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington"},{"name":"Harborview Medical Center, Seattle, Washington"},{"name":"School of Pharmacy, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Harrington","sequence":"additional","affiliation":[{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington"},{"name":"Harborview Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-4011","authenticated-orcid":false,"given":"Shireesha","family":"Dhanireddy","sequence":"additional","affiliation":[{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, School of Medicine, Seattle, Washington"},{"name":"Harborview Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"2020081003480633400_CIT0001","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijantimicag.2017.11.008","article-title":"Dalbavancin in the treatment of different gram-positive infections: a real-life experience","volume":"51","author":"Bouza","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2020081003480633400_CIT0002","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy279","article-title":"Dalbavancin as primary and sequential treatment for Gram-positive infective endocarditis: 2-year experience at the General Hospital of Vienna","author":"Tobudic","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2020081003480633400_CIT0003","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020081003480633400_CIT0004","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/jhm.2597","article-title":"Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients","volume":"11","author":"Beieler","year":"2016","journal-title":"J Hosp Med"},{"key":"2020081003480633400_CIT0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/NAN.0000000000000165","article-title":"Oral parenteral antimicrobial therapy administration in a homeless population","volume":"39","author":"Hernandez","year":"2016","journal-title":"J Infus Nurs"},{"key":"2020081003480633400_CIT0006","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/jac\/dkq355","article-title":"Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service","volume":"65","author":"Ho","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"X","key":"2020081003480633400_CIT0007","first-page":"XXX","article-title":"Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users","volume":"4","author":"Buehrle","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020081003480633400_CIT0008","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/ofid\/ofw172.1033","article-title":"Outpatient antibiotic treatment outcomes in vulnerable populations: homeless and current injection drug users","volume":"3","author":"Zhou","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"X","key":"2020081003480633400_CIT0009","first-page":"XXX","article-title":"Outcomes according to discharge location for persons who inject drugs receiving outpatient parenteral antimicrobial therapy","volume":"5","author":"D\u2019Couto","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020081003480633400_CIT0010","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1093\/ofid\/ofx163.811","article-title":"Implementation of a standardized protocol for hospitalized patients who inject drugs and require long-term antibiotics reduces length of stay without increasing 30-day readmissions","volume":"4","author":"Rolfe","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020081003480633400_CIT0011","doi-asserted-by":"crossref","first-page":"e0141594","DOI":"10.1371\/journal.pone.0141594","article-title":"Factors associated with leaving hospital against medical advice among people who use illicit drugs in Vancouver, Canada","volume":"10","author":"Ti","year":"2015","journal-title":"PLoS One"},{"key":"2020081003480633400_CIT0012","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s11606-010-1371-4","article-title":"Leaving against medical advice (AMA): risk of 30-day mortality and hospital readmission","volume":"25","author":"Glasgow","year":"2010","journal-title":"J Gen Intern Med"},{"key":"2020081003480633400_CIT0013","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2020081003480633400_CIT0014","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","article-title":"Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens","volume":"40","author":"Raad","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020081003480633400_CIT0015","doi-asserted-by":"crossref","first-page":"ofy331","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: A randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2018","journal-title":"Open Forum Infec Dis"},{"key":"2020081003480633400_CIT0016","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1093\/ofid\/ofx163.788","article-title":"Follow-up appointment adherence of outpatient parenteral antimicrobial therapy (OPAT) patients","volume":"4","author":"Lall","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2020081003480633400_CIT0017","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12788\/jhm.3138","article-title":"Outpatient parenteral antimicrobial therapy in vulnerable populations - people who inject drugs and the homeless","volume":"14","author":"Beieler","year":"2019","journal-title":"J Hosp Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz028\/33575442\/ofz028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz028\/33575442\/ofz028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T08:01:48Z","timestamp":1597046508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz028\/5304406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz028","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,1,30]]},"article-number":"ofz028"}}